Stay updated with breaking news from Junshi Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The "Global TROP2 Antibody Market & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.com's offering. The global Trop2...
/PRNewswire/ -- The "Global TROP2 Antibody Market & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.com's offering. The global Trop2...
The NRDL, a compilation that has existed for two decades, is part of the Chinese government’s plan to make health care affordable and accessible under the country’s socialist principles. Formally adopted in 2017 as an annual list, it forms part of the “common prosperity” aspiration pledged by President Xi Jinping.
FDA has granted the toripalimab BLA Priority Review with a target action date of April 2022SHANGHAI, China and REDWOOD CITY, Calif., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd.
/PRNewswire/ -- The "Neuroendocrine Tumors - Global Drug Forecast and Market Analysis to 2030" report has been added to ResearchAndMarkets.com's offering. The...